Unlikely to cause harm — often a labeling or packaging issue.
Cross contamination with other products.
| Brand name | VERAPAMIL HYDROCHLORIDE |
| Generic name | VERAPAMIL HYDROCHLORIDE |
| Active ingredient(s) | VERAPAMIL HYDROCHLORIDE |
| Distributed by / for | Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534 |
| NDC | 70710-1643-1 |
| Full product label | Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534, |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | Nationwide in the USA |
| Quantity | 170,755 vials |
| Recall initiated | 2024-07-02 |
| Report date | 2024-07-17 |
| Recall completed | — |
| Recall number | D-0592-2024 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗